Alley Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $15.6M | Buy |
115,379
+1,461
| +1% | +$173K | 2.48% | 14 |
|
|
2021
Q3 | $12.3M | Buy |
113,918
+2,510
| +2% | +$287K | 2.2% | 18 |
|
|
2021
Q2 | $12.5M | Buy |
111,408
+484
| +0.4% | +$54.5K | 2.28% | 16 |
|
|
2021
Q1 | $12M | Buy |
110,924
+863
| +0.8% | +$92.3K | 2.37% | 14 |
|
|
2020
Q4 | $11.8M | Sell |
110,061
-371,022
| -77% | -$35.7M | 2.45% | 15 |
|
|
2020
Q3 | $42.1M | Buy |
481,083
+1,960
| +0.4% | +$185K | 3.05% | 12 |
|
|
2020
Q2 | $47M | Buy |
479,123
+118,958
| +33% | +$10.5M | 3.64% | 3 |
|
|
2020
Q1 | $27.4M | Buy |
360,165
+264,467
| +276% | +$22.5M | 3.17% | 8 |
|
|
2019
Q4 | $8.47M | Buy |
95,698
+6,349
| +7% | +$527K | 2.18% | 17 |
|
|
2019
Q3 | $6.77M | Buy |
89,349
+517
| +0.6% | +$35.4K | 1.85% | 21 |
|
|
2019
Q2 | $6.46M | Buy |
88,832
+264
| +0.3% | +$20.8K | 1.83% | 22 |
|
|
2019
Q1 | $7.14M | Buy |
88,568
+3,131
| +4% | +$256K | 2.1% | 17 |
|
|
2018
Q4 | $7.88M | Sell |
85,437
-1,573
| -2% | -$138K | 2.59% | 9 |
|
|
2018
Q3 | $8.23M | Buy |
87,010
+1,945
| +2% | +$184K | 2.52% | 13 |
|
|
2018
Q2 | $7.88M | Buy |
85,065
+95
| +0.1% | +$9.28K | 2.65% | 7 |
|
|
2018
Q1 | $8.04M | Buy |
84,970
+43,884
| +107% | +$4.82M | 2.76% | 5 |
|
|
2017
Q4 | $3.97M | Sell |
41,086
-1,000
| -2% | -$94.2K | 1.36% | 33 |
|
|
2017
Q3 | $3.74M | Hold |
42,086
| – | – | 1.36% | 35 |
|
|
2017
Q2 | $3.05M | Sell |
42,086
-1,000
| -2% | -$67.2K | 1.15% | 38 |
|
|
2017
Q1 | $2.81M | Hold |
43,086
| – | – | 1.11% | 39 |
|
|
2016
Q4 | $2.7M | Sell |
43,086
-2,500
| -5% | -$153K | 1.19% | 39 |
|
|
2016
Q3 | $2.88M | Buy |
45,586
+244
| +0.5% | +$15.8K | 1.28% | 36 |
|
|
2016
Q2 | $2.81M | Hold |
45,342
| – | – | 1.28% | 35 |
|
|
2016
Q1 | $2.59M | Sell |
45,342
-77,106
| -63% | -$4.3M | 1.24% | 36 |
|
|
2015
Q4 | $7.25M | Buy |
122,448
+2,173
| +2% | +$125K | 3.54% | 2 |
|
|
2015
Q3 | $6.54M | Buy |
120,275
+191
| +0.2% | +$12.4K | 3.37% | 4 |
|
|
2015
Q2 | $8.07M | Sell |
120,084
-289
| -0.2% | -$18.9K | 3.97% | 1 |
|
|
2015
Q1 | $7.05M | Sell |
120,373
-14,370
| -11% | -$868K | 3.45% | 4 |
|
|
2014
Q4 | $8.82M | Buy |
134,743
+86,308
| +178% | +$5.44M | 4.53% | 1 |
|
|
2014
Q3 | $2.8M | Buy |
48,435
+597
| +1% | +$33.1K | 2.02% | 16 |
|
|
2014
Q2 | $2.7M | Sell |
47,838
-2,965
| -6% | -$156K | 1.92% | 16 |
|
|
2014
Q1 | $2.61M | Buy |
50,803
+1,889
| +4% | +$95.5K | 1.84% | 20 |
|
|
2013
Q4 | $2.58M | Buy |
48,914
+43
| +0.1% | +$2.11K | 1.87% | 19 |
|
|
2013
Q3 | $2.19M | Buy |
48,871
+950
| +2% | +$42.1K | 1.75% | 20 |
|
|
2013
Q2 | $1.98M | Buy |
+47,921
| New | +$2.1M | 1.65% | 22 |
|
Other funds holding ABBV
Alley Company's ABBV Position: Q4 2021 in Review
Alley Company increased its AbbVie (ABBV) stake by 1.3% in Q4 2021, buying an estimated $173K and bringing the position to 115,379 shares worth $15.6M. The position accounts for 2.48% of the portfolio, ranked #14.
Alley Company first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. The position peaked at $47M in Q2 2020. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- Alley Company held 115,379 shares of AbbVie worth $15.6M as of Q4 2021.
- Alley Company bought 1,461 AbbVie shares in Q4 2021, an estimated $173K.
- AbbVie made up 2.48% of Alley Company's portfolio in Q4 2021, its #14 holding.
- Alley Company first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- Alley Company's AbbVie position peaked at $47M in Q2 2020.
- 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on Alley Company's 13F filing for Q4 2021, filed 25 Jan 2022.